Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data for the novel, potential ...
Ribometrix, a biotechnology company developing small molecule therapeutics that modulate RNA biology, presented the latest ...
Summit Therapeutics presents updated Ivonescimab data from phase II studies at ESMO 2024 annual meeting: Miami Wednesday, September 18, 2024, 15:00 Hrs [IST] Summit Therapeutics I ...
Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...
3don MSN
After avoiding a clash at the box office with Rajinikanth’s Vettaiyan, makers of Kanguva drop a scintillating motion poster ...
Between June 5 and December 12, 2023, ten adult patients with advanced ccRCC who received a median of four prior treatment lines (range: 2-7) were enrolled and received a median of three cycles (range ...
Netflix brings in Joe Manganiello and Lera Abova on board as the cast of One Piece season 2. Read on for the details.
The ESMO Proferred Paper Oral Presentation slides are available on the Posters & Publications section of Immutep ... 5 ...
The recent ESMO 2024 data highlighted significant advancements in immunotherapy. Check out the results from Merck, BMY, ...
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback